To sum up, these results suggested that by simultaneous inhibition of the FGFR1 pathway and autophagy, CP@NP‐cRGD could sharply induce apoptosis and decrease proliferation in AZD9291‐resistant NSCLC tumor in vivo. The gene discussed is FGFR1; the disease is non-small cell lung carcinoma.